Dose-dependent transitions in mechanisms of toxicity: Case studies

William Slikker; Melvin E. Andersen; Matthew S. Bogdanffy; James S. Bus; Steven D. Cohen; Rory B. Conolly; Raymond M. David; Nancy G. Doerrer; David C. Dorman; David W. Gaylor; Dale Hattis; John M. Rogers; R. Woodrow Setzer; James A. Swenberg; Kendall Wallace

doi:10.1016/j.taap.2004.06.027

Dose-dependent transitions in mechanisms of toxicity: Case studies

William Slikker, Melvin E. Andersen, Matthew S. Bogdanffy, James S. Bus, Steven D. Cohen, Rory B. Conolly, Raymond M. David, Nancy G. Doerrer, David C. Dorman, David W. Gaylor, Dale Hattis, John M. Rogers, R. Woodrow Setzer, James A. Swenberg, Kendall Wallace

Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

159 Scopus citations

Abstract

Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full dose-response curve. It is highly likely that critical, limiting steps in any given mechanistic pathway may become overwhelmed with increasing exposures, signaling the emergence of new modalities of toxic tissue injury at these higher doses. Therefore, dose-dependent transitions in principal mechanisms of toxicity may occur, and could have significant impact on the interpretation of reference data sets for risk assessment. To illustrate the existence of dose-dependent transitions in mechanisms of toxicity, a group of academic, government, and industry scientists, formed under the leadership of the ILSI Health and Environmental Sciences Institute (HESI), developed a series of case studies. These case studies included acetaminophen, butadiene, ethylene glycol, formaldehyde, manganese, methylene chloride, peroxisome proliferator-activated receptor (PPAR), progesterone/hydroxyflutamide, propylene oxide, vinyl acetate, vinyl chloride, vinylidene chloride, and zinc. The case studies formed the basis for technical discourse at two scientific workshops in 2003.

Original language	English (US)
Pages (from-to)	226-294
Number of pages	69
Journal	Toxicology and Applied Pharmacology
Volume	201
Issue number	3
DOIs	https://doi.org/10.1016/j.taap.2004.06.027
State	Published - Dec 15 2004

Bibliographical note

Funding Information:
The HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity extends its appreciation to the HESI Project Committee on the Use of Mechanistic Data in Risk Assessment for providing the scientific foundation, as well as financial support, for the development of these case studies. Appreciation is also extended to Samuel M. Cohen (University of Nebraska Medical Center), Curtis D. Klaassen (University of Kansas Medical Center), and James E. Klaunig (Indiana University School of Medicine) for their careful scientific review of this manuscript prior to submission for publication. The HESI Project Committee thanks Ms. Cyndi Nobles (ILSI Health and Environmental Sciences Institute) for her excellent administrative support during the project. About HESI The ILSI Health and Environmental Sciences Institute (HESI) is a global branch of the International Life Sciences Institute, a public, non-profit scientific foundation with branches throughout the world. HESI provides an international forum to advance the undestanding and application of scientific issues related to human health, toxicology, risk assessment, and the environment. HESI is widely recognized among scientists from government, industry, and academia as an objective, science-based organization within which important issues of mutual concern can be discussed and resolved in the interest of improving public health. As part of its public benefit mandate, HESI's activities are carried out in the public domain, generating data and other information for broad scientific use and application. Further information about HESI can be found at http://hesi.ilsi.org .

Keywords

Acetaminophen
Butadiene, ethylene glycol
Dose response
Dose-dependent transitions
Formaldehyde
Manganese
Mechanisms of toxicity
Methylene chloride
Peroxisome proliferator-activated receptor
Progesterone/ hydroxyflutamide
Propylene oxide
Vinyl acetate

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.taap.2004.06.027

Find It

Find It at U of M Libraries

Cite this

Slikker, W., Andersen, M. E., Bogdanffy, M. S., Bus, J. S., Cohen, S. D., Conolly, R. B., David, R. M., Doerrer, N. G., Dorman, D. C., Gaylor, D. W., Hattis, D., Rogers, J. M., Setzer, R. W., Swenberg, J. A., & Wallace, K. (2004). Dose-dependent transitions in mechanisms of toxicity: Case studies. Toxicology and Applied Pharmacology, 201(3), 226-294. https://doi.org/10.1016/j.taap.2004.06.027

@article{c6a878dfad6d420a805c005902d92ea4,

title = "Dose-dependent transitions in mechanisms of toxicity: Case studies",

abstract = "Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full dose-response curve. It is highly likely that critical, limiting steps in any given mechanistic pathway may become overwhelmed with increasing exposures, signaling the emergence of new modalities of toxic tissue injury at these higher doses. Therefore, dose-dependent transitions in principal mechanisms of toxicity may occur, and could have significant impact on the interpretation of reference data sets for risk assessment. To illustrate the existence of dose-dependent transitions in mechanisms of toxicity, a group of academic, government, and industry scientists, formed under the leadership of the ILSI Health and Environmental Sciences Institute (HESI), developed a series of case studies. These case studies included acetaminophen, butadiene, ethylene glycol, formaldehyde, manganese, methylene chloride, peroxisome proliferator-activated receptor (PPAR), progesterone/hydroxyflutamide, propylene oxide, vinyl acetate, vinyl chloride, vinylidene chloride, and zinc. The case studies formed the basis for technical discourse at two scientific workshops in 2003.",

keywords = "Acetaminophen, Butadiene, ethylene glycol, Dose response, Dose-dependent transitions, Formaldehyde, Manganese, Mechanisms of toxicity, Methylene chloride, Peroxisome proliferator-activated receptor, Progesterone/ hydroxyflutamide, Propylene oxide, Vinyl acetate",

author = "William Slikker and Andersen, {Melvin E.} and Bogdanffy, {Matthew S.} and Bus, {James S.} and Cohen, {Steven D.} and Conolly, {Rory B.} and David, {Raymond M.} and Doerrer, {Nancy G.} and Dorman, {David C.} and Gaylor, {David W.} and Dale Hattis and Rogers, {John M.} and Setzer, {R. Woodrow} and Swenberg, {James A.} and Kendall Wallace",

note = "Funding Information: The HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity extends its appreciation to the HESI Project Committee on the Use of Mechanistic Data in Risk Assessment for providing the scientific foundation, as well as financial support, for the development of these case studies. Appreciation is also extended to Samuel M. Cohen (University of Nebraska Medical Center), Curtis D. Klaassen (University of Kansas Medical Center), and James E. Klaunig (Indiana University School of Medicine) for their careful scientific review of this manuscript prior to submission for publication. The HESI Project Committee thanks Ms. Cyndi Nobles (ILSI Health and Environmental Sciences Institute) for her excellent administrative support during the project. About HESI The ILSI Health and Environmental Sciences Institute (HESI) is a global branch of the International Life Sciences Institute, a public, non-profit scientific foundation with branches throughout the world. HESI provides an international forum to advance the undestanding and application of scientific issues related to human health, toxicology, risk assessment, and the environment. HESI is widely recognized among scientists from government, industry, and academia as an objective, science-based organization within which important issues of mutual concern can be discussed and resolved in the interest of improving public health. As part of its public benefit mandate, HESI's activities are carried out in the public domain, generating data and other information for broad scientific use and application. Further information about HESI can be found at http://hesi.ilsi.org . ",

year = "2004",

month = dec,

day = "15",

doi = "10.1016/j.taap.2004.06.027",

language = "English (US)",

volume = "201",

pages = "226--294",

journal = "Toxicology and Applied Pharmacology",

issn = "0041-008X",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Dose-dependent transitions in mechanisms of toxicity

T2 - Case studies

AU - Slikker, William

AU - Andersen, Melvin E.

AU - Bogdanffy, Matthew S.

AU - Bus, James S.

AU - Cohen, Steven D.

AU - Conolly, Rory B.

AU - David, Raymond M.

AU - Doerrer, Nancy G.

AU - Dorman, David C.

AU - Gaylor, David W.

AU - Hattis, Dale

AU - Rogers, John M.

AU - Setzer, R. Woodrow

AU - Swenberg, James A.

AU - Wallace, Kendall

N1 - Funding Information: The HESI Project Committee on Dose-Dependent Transitions in Mechanisms of Toxicity extends its appreciation to the HESI Project Committee on the Use of Mechanistic Data in Risk Assessment for providing the scientific foundation, as well as financial support, for the development of these case studies. Appreciation is also extended to Samuel M. Cohen (University of Nebraska Medical Center), Curtis D. Klaassen (University of Kansas Medical Center), and James E. Klaunig (Indiana University School of Medicine) for their careful scientific review of this manuscript prior to submission for publication. The HESI Project Committee thanks Ms. Cyndi Nobles (ILSI Health and Environmental Sciences Institute) for her excellent administrative support during the project. About HESI The ILSI Health and Environmental Sciences Institute (HESI) is a global branch of the International Life Sciences Institute, a public, non-profit scientific foundation with branches throughout the world. HESI provides an international forum to advance the undestanding and application of scientific issues related to human health, toxicology, risk assessment, and the environment. HESI is widely recognized among scientists from government, industry, and academia as an objective, science-based organization within which important issues of mutual concern can be discussed and resolved in the interest of improving public health. As part of its public benefit mandate, HESI's activities are carried out in the public domain, generating data and other information for broad scientific use and application. Further information about HESI can be found at http://hesi.ilsi.org .

PY - 2004/12/15

Y1 - 2004/12/15

N2 - Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full dose-response curve. It is highly likely that critical, limiting steps in any given mechanistic pathway may become overwhelmed with increasing exposures, signaling the emergence of new modalities of toxic tissue injury at these higher doses. Therefore, dose-dependent transitions in principal mechanisms of toxicity may occur, and could have significant impact on the interpretation of reference data sets for risk assessment. To illustrate the existence of dose-dependent transitions in mechanisms of toxicity, a group of academic, government, and industry scientists, formed under the leadership of the ILSI Health and Environmental Sciences Institute (HESI), developed a series of case studies. These case studies included acetaminophen, butadiene, ethylene glycol, formaldehyde, manganese, methylene chloride, peroxisome proliferator-activated receptor (PPAR), progesterone/hydroxyflutamide, propylene oxide, vinyl acetate, vinyl chloride, vinylidene chloride, and zinc. The case studies formed the basis for technical discourse at two scientific workshops in 2003.

AB - Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full dose-response curve. It is highly likely that critical, limiting steps in any given mechanistic pathway may become overwhelmed with increasing exposures, signaling the emergence of new modalities of toxic tissue injury at these higher doses. Therefore, dose-dependent transitions in principal mechanisms of toxicity may occur, and could have significant impact on the interpretation of reference data sets for risk assessment. To illustrate the existence of dose-dependent transitions in mechanisms of toxicity, a group of academic, government, and industry scientists, formed under the leadership of the ILSI Health and Environmental Sciences Institute (HESI), developed a series of case studies. These case studies included acetaminophen, butadiene, ethylene glycol, formaldehyde, manganese, methylene chloride, peroxisome proliferator-activated receptor (PPAR), progesterone/hydroxyflutamide, propylene oxide, vinyl acetate, vinyl chloride, vinylidene chloride, and zinc. The case studies formed the basis for technical discourse at two scientific workshops in 2003.

KW - Acetaminophen

KW - Butadiene, ethylene glycol

KW - Dose response

KW - Dose-dependent transitions

KW - Formaldehyde

KW - Manganese

KW - Mechanisms of toxicity

KW - Methylene chloride

KW - Peroxisome proliferator-activated receptor

KW - Progesterone/ hydroxyflutamide

KW - Propylene oxide

KW - Vinyl acetate

UR - http://www.scopus.com/inward/record.url?scp=9944240752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9944240752&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2004.06.027

DO - 10.1016/j.taap.2004.06.027

M3 - Article

C2 - 15582646

AN - SCOPUS:9944240752

SN - 0041-008X

VL - 201

SP - 226

EP - 294

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

IS - 3

ER -

Dose-dependent transitions in mechanisms of toxicity: Case studies

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this